139 related articles for article (PubMed ID: 29333018)
41. Prognostic determinants of locally advanced buccal mucosa cancer: Do we need to relook the current staging criteria?
Pillai V; Yadav V; Kekatpure V; Trivedi N; Chandrashekar NH; Shetty V; Rangappa V; Subramaniam N; Bhat V; Raghavan N; Kolur T; George N; Thomas T; Kuriakose MA
Oral Oncol; 2019 Aug; 95():43-51. PubMed ID: 31345393
[TBL] [Abstract][Full Text] [Related]
42. Induction Chemotherapy for Locally Advanced Esophageal Cancer.
Harada G; Bonadio RRDCC; de Araújo FCC; Victor CR; Sallum RAA; Junior UR; Cecconello I; Takeda FR; de Castria TB
J Gastrointest Cancer; 2020 Jun; 51(2):498-505. PubMed ID: 31240598
[TBL] [Abstract][Full Text] [Related]
43. Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.
Kim S; François E; André T; Samalin E; Jary M; El Hajbi F; Baba-Hamed N; Pernot S; Kaminsky MC; Bouché O; Desrame J; Zoubir M; Ghiringhelli F; Parzy A; De La Fouchardiere C; Smith D; Deberne M; Spehner L; Badet N; Adotevi O; Anota A; Meurisse A; Vernerey D; Taieb J; Vendrely V; Buecher B; Borg C
Lancet Oncol; 2018 Aug; 19(8):1094-1106. PubMed ID: 30042063
[TBL] [Abstract][Full Text] [Related]
44. [Clinical efficacy of alternating chemo-radiotherapy for locally advanced nasopharyngeal carcinoma].
You X; Yang Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(6):376-80. PubMed ID: 24961123
[TBL] [Abstract][Full Text] [Related]
45. Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma.
Li X; Fang Q; Du W; Zhang X; Dai L; Qiao Y
BMC Cancer; 2021 May; 21(1):622. PubMed ID: 34044810
[TBL] [Abstract][Full Text] [Related]
46. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
47. Preoperative Chemotherapy and Metronomic Scheduling of Chemotherapy in Locally Advanced Oral Cancers.
Patil VM; Noronha V; Joshi A; Banavali SD; Muddu V; Prabhash K
Oncology; 2016; 91 Suppl 1():35-40. PubMed ID: 27463093
[TBL] [Abstract][Full Text] [Related]
48. Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC).
Garrido P; Engel-Riedel W; Serke M; Giraud P; Ricardi U; Vallejo C; Visseren-Grul C; Ameryckx S; Soldatenkova V; Chouaki N; Novello S
Lung Cancer; 2015 May; 88(2):160-6. PubMed ID: 25758556
[TBL] [Abstract][Full Text] [Related]
49. The predictive value of
Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
[TBL] [Abstract][Full Text] [Related]
50. Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study).
Folprecht G; Gruenberger T; Bechstein W; Raab HR; Weitz J; Lordick F; Hartmann JT; Stoehlmacher-Williams J; Lang H; Trarbach T; Liersch T; Ockert D; Jaeger D; Steger U; Suedhoff T; Rentsch A; Köhne CH
Ann Oncol; 2014 May; 25(5):1018-25. PubMed ID: 24585720
[TBL] [Abstract][Full Text] [Related]
51. A Phase II Study of Genexol-PM and Cisplatin as Induction Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma.
Keam B; Lee KW; Lee SH; Kim JS; Kim JH; Wu HG; Eom KY; Kim S; Ahn SH; Chung EJ; Kwon SK; Jeong WJ; Jung YH; Kim JW; Heo DS
Oncologist; 2019 Jun; 24(6):751-e231. PubMed ID: 30796155
[TBL] [Abstract][Full Text] [Related]
52. Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction.
Choong NW; Mauer AM; Haraf DC; Ferguson MK; Sandler AB; Kesler KA; Fishkin PA; Ansari RH; Wade J; Krauss SA; Sciortino DF; Posner MC; Kocherginsky M; Hoffman PC; Szeto L; Vokes EE
Med Oncol; 2011 Dec; 28 Suppl 1():S152-61. PubMed ID: 20730572
[TBL] [Abstract][Full Text] [Related]
53. Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.
Dagan O; Moore A; Nachalon Y; Alkan U; Biadsee A; Shochat I; Popovtzer A
Head Neck; 2020 Nov; 42(11):3118-3124. PubMed ID: 32671892
[TBL] [Abstract][Full Text] [Related]
54. Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil.
Abe T; Higaki E; Hosoi T; Nagao T; Bando H; Kadowaki S; Muro K; Tanaka T; Tajika M; Niwa Y; Shimizu Y
Ann Surg Oncol; 2021 Feb; 28(2):712-721. PubMed ID: 32761331
[TBL] [Abstract][Full Text] [Related]
55. Preoperative chemotherapy of locally advanced gastric cancer.
Rougier P; Lasser P; Ducreux M; Mahjoubi M; Bognel C; Elias D
Ann Oncol; 1994; 5 Suppl 3():59-68. PubMed ID: 8204531
[TBL] [Abstract][Full Text] [Related]
56. Radiological response and survival in locally advanced non-small-cell lung cancer patients treated with three-drug induction chemotherapy followed by radical local treatment.
Bonanno L; Zago G; Marulli G; Del Bianco P; Schiavon M; Pasello G; Polo V; Canova F; Tonetto F; Loreggian L; Rea F; Conte P; Favaretto A
Onco Targets Ther; 2016; 9():3671-81. PubMed ID: 27382305
[TBL] [Abstract][Full Text] [Related]
57. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic factors of patients with unresectable liver metastasis from colorectal cancer after failed conversion chemotherapy].
He H; Shen W; Chen W; Liu H; Gong W; Fu J; Hu X; Cui L
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Nov; 21(11):1261-1267. PubMed ID: 30506537
[TBL] [Abstract][Full Text] [Related]
59. Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma.
Le Roy B; Gelli M; Pittau G; Allard MA; Pereira B; Serji B; Vibert E; Castaing D; Adam R; Cherqui D; Sa Cunha A
Br J Surg; 2018 Jun; 105(7):839-847. PubMed ID: 28858392
[TBL] [Abstract][Full Text] [Related]
60. Multidisciplinary approach in advanced cancer of the oral cavity: outcome with neoadjuvant chemotherapy according to intention-to-treat local therapy. A phase II study.
Grau JJ; Domingo J; Blanch JL; Verger E; Castro V; Nadal A; Alós L; Estapé J
Oncology; 2002; 63(4):338-45. PubMed ID: 12417788
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
